Gene therapy: Comprehensive overview and therapeutic applications

N Sayed, P Allawadhi, A Khurana, V Singh, U Navik… - Life sciences, 2022 - Elsevier
Gene therapy is the product of man's quest to eliminate diseases. Gene therapy has three
facets namely, gene silencing using siRNA, shRNA and miRNA, gene replacement where …

[HTML][HTML] From conventional therapies to immunotherapy: melanoma treatment in review

L Kuryk, L Bertinato, M Staniszewska, K Pancer… - Cancers, 2020 - mdpi.com
Simple Summary Here, we review the current state of knowledge in the field of cancer
immunotherapy, focusing on the scientific rationale for the use of oncolytic viruses …

[HTML][HTML] Toxicologic concerns with current medical nanoparticles

TM Cheng, HY Chu, HM Huang, ZL Li… - International journal of …, 2022 - mdpi.com
Nanotechnology is one of the scientific advances in technology. Nanoparticles (NPs) are
small materials ranging from 1 to 100 nm. When the shape of the supplied nanoparticles …

[HTML][HTML] Self-replicating RNA viruses for vaccine development against infectious diseases and cancer

K Lundstrom - Vaccines, 2021 - mdpi.com
Alphaviruses, flaviviruses, measles viruses and rhabdoviruses are enveloped single-
stranded RNA viruses, which have been engineered for recombinant protein expression and …

[HTML][HTML] Viruses as tools in gene therapy, vaccine development, and cancer treatment

M bin Umair, FN Akusa, H Kashif, F Butt, M Azhar… - Archives of …, 2022 - Springer
Using viruses to our advantage has been a huge leap for humanity. Their ability to mediate
horizontal gene transfer has made them useful tools for gene therapy, vaccine development …

[HTML][HTML] Application of viral vectors for vaccine development with a special emphasis on COVID-19

K Lundstrom - Viruses, 2020 - mdpi.com
Viral vectors can generate high levels of recombinant protein expression providing the basis
for modern vaccine development. A large number of different viral vector expression systems …

[HTML][HTML] Aptamers enhance oncolytic viruses' antitumor efficacy

MA Dymova, AS Kichkailo, EV Kuligina, VA Richter - Pharmaceutics, 2022 - mdpi.com
Oncolytic viruses are highly promising for cancer treatment because they target and lyse
tumor cells. These genetically engineered vectors introduce therapeutic or …

[HTML][HTML] Dendrimers as non-viral vectors in gene-directed enzyme prodrug therapy

AA Chis, CM Dobrea, LL Rus, A Frum, C Morgovan… - Molecules, 2021 - mdpi.com
Gene-directed enzyme prodrug therapy (GDEPT) has been intensively studied as a
promising new strategy of prodrug delivery, with its main advantages being represented by …

Overcoming the blood–brain barrier in neurodegenerative disorders and brain tumours

Z Ebrahimi, S Talaei, S Aghamiri… - IET …, 2020 - Wiley Online Library
Drug delivery is one of the major challenges in the treatment of central nervous system
disorders. The brain needs to be protected from harmful agents, which are done by the …

Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape

JSR Viegas, MVLB Bentley… - Journal of Drug Delivery …, 2022 - Elsevier
The gene therapy is an alternative approach to melanoma treatments due to several drug
resistance that this type of cancer developed and to perform an efficiently in vivo gene …